Newry based Duality Healthcare has appointed Michael Donnelly as Chairman as it prepares for significant investment and growth following a £4.5 million funding round earlier this year.
Michael, a Belfast native with over 25 years of experience as a senior strategic adviser, investment professional and Chartered Accountant, will take on the challenge of supporting private GP provider Duality Healthcare as it continues to expand. His extensive background spans infrastructure, regulated sectors and private capital in London, Dublin and Belfast.
He previously worked as fund manager for a FTSE 250 investment vehicle with Quintain Estates and Development, and acted as an adviser to shareholders of KN Group, now Circet, during a period of rapid international expansion. Currently, alongside his new role with Duality Healthcare, he serves as Head of Financial and Commercial Advisory at the Strategic Investment Board on a part time basis, supporting Ministers and departments on complex multi-million pound portfolios. He is also an active private investor and adviser to early-stage and scaling companies, with a particular focus on governance, capital discipline and strategic clarity.
Michael said he is excited to take on the role as the company "Duality Healthcare is addressing a genuine and growing challenge within the healthcare system: access to timely, high-quality care delivered in a way that is clinically robust, patient-centred and scalable. What distinguishes Duality is that it is not simply a technology platform, it is a healthcare business built around clinical leadership, real-world delivery and an understanding of regulatory and operational realities. That combination gives it strong foundations for sustainable growth," he said.
He believes Duality has significant potential to become a truly trusted provider within the UK healthcare landscape, particularly as health systems look for innovative models that improve access and outcomes while remaining cost-effective. "With disciplined governance and a clear growth strategy, the business is very well-placed to scale responsibly," Michael said.
His role will be to ensure the board operates effectively, with clear accountability, constructive challenge and strong decision-making, as well as to support management in balancing clinical quality, patient outcomes and commercial sustainability. "I will also be working to ensure very robust financial oversight, governance frameworks and risk management as the organisation grows, and ultimately help position Duality as a highly credible, truly trusted partner to patients, clinicians, commissioners, investors and regulators," he added.
John McEvoy, CEO of Duality Healthcare, welcomed the appointment, saying Michael's considerable expertise and experience will be invaluable as the company delivers accessible, high-quality, affordable healthcare to communities across Northern Ireland. "We are redefining how people experience primary care through improved access, enhanced outcomes, and building a system that truly works for patients," he said.
The company currently employs over 50 people with clinics in Newry, Ballymena, Omagh and Derry, with more planned this year. The funding secured earlier in 2025 will accelerate the launch of new clinics, further expansion of healthcare services and the creation of up to 80 new jobs across Northern Ireland. Duality Healthcare recently announced an innovative partnership with Gordon's Chemists aimed at bringing enhanced virtual and face-to-face GP services to communities across the north.


